Elevated serum levels of macrophage migration inhibitory factor and their significant correlation with rheumatoid vasculitis disease activity

References

• Vollertsen RS, Conn DL. Vasculitis associated with rheumatoid arthritis. Rheum Dis Clin North Am. 1990;16:445–61.
   PubMed Web of Science ®Google Scholar
• Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med. 2001;344:907–16.
   PubMed Web of Science ®Google Scholar
• Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423:356–61.
   PubMed Web of Science ®Google Scholar
• Bloom BR, Bennett B. Mechanism of a reaction in vitro associ-ated with delayed-type hypersensitivity. Science. 1966;153:80–2.
   PubMed Web of Science ®Google Scholar
• Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 2003; 3:791–800.
   PubMed Web of Science ®Google Scholar
• Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macro-phage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med. 1994; 179:1895–902.
   PubMed Web of Science ®Google Scholar
• Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA. 1996;93:7849–54.
   PubMed Web of Science ®Google Scholar
• Daryadel A, Grifone RF, Simon HU, Yousefi S. Apoptotic neu-trophils release macrophage migration inhibitory factor upon stimulation with tumor necrosis factor-alpha. J Biol Chem. 2006;281:27653–61.
   PubMed Web of Science ®Google Scholar
• Nishihira J, Koyama Y, Mizue Y. Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide. Cytokine. 1998;10:199–205.
   Google Scholar
• Onodera S, Suzuki K, Matsuno T, Kaneda K, Takagi M, Nishihira J. Macrophage migration inhibitory factor induces phagocytosis of foreign particles by macrophages in autocrine and paracrine fashion. Immunology. 1997;92:131–7.
   PubMed Web of Science ®Google Scholar
• Froidevaux C, Roger T, Martin C, Glauser MP, Calandra T. Macrophage migration inhibitory factor and innate immune responses to bacterial infections. Crit Care Med. 2001;29:513–5.
   Google Scholar
• Bernhagen J, Mitchell RA, Calandra T, Voelter W, Cerami A, Bucala R. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry. 1994;33:14144–55.
   PubMed Web of Science ®Google Scholar
• Cunha FQ, Weiser WY, David JR, Moss DW, Moncada S, Liew FY. Recombinant migration inhibitory factor induces nitric oxide synthase in murine macrophages. J Immunol. 1993;150:1908–12.
   PubMed Web of Science ®Google Scholar
• Leech M, Metz C, Hall P, Hutchinson P, Gianis K, Smith M, et al. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by gluco-corticoids. Arthritis Rheum. 1999;42:1601–8.
   PubMed Web of Science ®Google Scholar
• Santos LL, Morand EF. Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosis. Clin Chim Acta. 2009;399:1–7.
   PubMed Web of Science ®Google Scholar
• Foote A, Briganti EM, Kipen Y, Santos L, Leech M, Morand EF. Macrophage migration inhibitory factor in systemic lupus ery-thematosus. J Rheumatol. 2004;31:268–73.
   PubMed Web of Science ®Google Scholar
• Selvi E, Tripodi SA, Catenaccio M, Lorenzini S, Chindamo D, Manganelli S, et al. Expression of macrophage migration inhib-itory factor in diffuse systemic sclerosis. Ann Rheum Dis. 2003;62:460–4.
   PubMed Web of Science ®Google Scholar
• Kozaci LD, Sari I, Alacacioglu A, Akar S, Akkoc N. Evaluation of inflammation and oxidative stress in ankylosing spondyfitis: a role for macrophage migration inhibitory factor. Mod Rheumatol. 2009;20:34–9.
   Google Scholar
• de Jong YP, Abadia-Molina AC, Satoskar AR, Clarke K, Rietdijk ST, Faubion WA, et al. Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol. 2001;2:1061–6.
   PubMed Web of Science ®Google Scholar
• Becker H, Maaser C, Mickholz E, Dyong A, Domschke W, Gaubitz M. Relationship between serum levels of macrophage migration inhibitory factor and the activity of antineutrophil cytoplasmic antibody-associated vasculitides. Clin Rheumatol. 2006;25:368–72.
   PubMed Web of Science ®Google Scholar
• Kanemitsu H, Matsunawa M, Wakabayashi K, Sato M, Takahashi R, Odai T, et al. Increased serum levels of macrophage migration inhibitory factor (MIF) in patients with microscopic polyangiitis. Open Access Rheumatol Res Rev. 2009;1:1–8.
   PubMedGoogle Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Boffa MC, Karmochkine M. Thrombomodulin: an overview and potential implications in vascular disorders. Lupus. 1998; 7(Suppl 2):S120–5.
   PubMedGoogle Scholar
• Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham Vascufitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM. 1994;87:671–8.
   PubMed Web of Science ®Google Scholar
• Calandra T, Bemhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature. 1995;377:68–71.
   PubMed Web of Science ®Google Scholar
• Onodera S, Tanji H, Suzuki K, Kaneda K, Mizue Y, Sagawa A, et al. High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints. Cytokine. 1999;11:163–7.
   PubMed Web of Science ®Google Scholar
• Ohdama S, Takano S, Miyake S, Kubota T, Sato K, Aoki N. Plasma thrombomodulin as a marker of vascular injuries in col-lagen vascular diseases. Am J Clin Pathol. 1994;101:109–13.
   PubMed Web of Science ®Google Scholar
• Boehme MW, Schmitt WH, Youinou P, Stremmel WR, Gross WL. Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vascufitides. Am J Med. 1996;101:387–94.
   Google Scholar
• Voskuyl AE, Hazes JM, Zwinderman AH, Paleolog EM, van der Meer FJ, Daha MR, et al. Diagnostic strategy for the assessment of rheumatoid vasculitis. Ann Rheum Dis. 2003;62:407–13.
   PubMed Web of Science ®Google Scholar
• Scott DG, Bacon PA, Allen C, Elson CJ, Wallington T. IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy. Clin Exp Immunol. 1981; 43:54–63.
   Google Scholar
• Breedveld FC, Heurkens AH, Lafeber GJ, van Hinsbergh VW, Cats A. Immune complexes in sera from patients with rheumatoid vasculitis induce polymorphonuclear cell-mediated injury to endothelial cells. Clin Immunol Immunopathol. 1988;48:202–13.
   Google Scholar
• Lozada C, Levin RI, Huie M, Hirschhom R, Naime D, Whitlow M, et al. Identification of Clq as the heat-labile serum cofactor required for immune complexes to stimulate endothelial expres-sion of the adhesion molecules E-selectin and intercellular and vascular cell adhesion molecules 1. Proc Natl Acad Sci USA. 1995;92:8378–82.
   PubMed Web of Science ®Google Scholar
• Bradley JR, Lockwood CM, Thiru S. Endothelial cell activation in patients with systemic vasculitis. QJM. 1994;87:741–5.
   Google Scholar
• Johnson PA, Alexander HD, McMillan SA, Maxwell AP. Up-regulation of the endothelial cell adhesion molecule intercellular adhesion molecule-1 (ICAM-1) by autoantibodies in autoimmune vasculitis. Clin Exp Immunol. 1997;108:234–42.
   PubMed Web of Science ®Google Scholar
• Sundy JS, Haynes BF. Cytokines and adhesion molecules in the pathogenesis of vasculitis. Curr Rheumatol Rep. 2000; 2:402–10.
   PubMedGoogle Scholar
• Lin SG, Yu XY, Chen YX, Huang XR, Metz C, Bucala R, et al. De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits. Circ Res. 2000;87:1202–8.
   PubMed Web of Science ®Google Scholar
• Onodera S, Nishihira J, Koyama Y, Majima T, Aoki Y, Ichiyama H, et al. Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibro-blasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-lbeta. Arthritis Rheum. 2004;50:1437–47.
   PubMed Web of Science ®Google Scholar
• Cheng Q, McKeown SJ, Santos L, Santiago FS, Khachigian LM, Morand EF, et al. Macrophage migration inhibitory factor increases leukocyte-endothelial interactions in human endothelial cells via promotion of expression of adhesion molecules. J Immunol. 2010;185:1238–47.
   PubMed Web of Science ®Google Scholar
• Matsunawa M, Isozaki T, Odai T, Yajima N, Takeuchi HT, Negishi M, et al. Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vascu-litis. Arthritis Rheum. 2006;54:3408–16.
   PubMed Web of Science ®Google Scholar
• Fong AM, Robinson LA, Steeber DA, Tedder TF, Yoshie 0, Imai T, et al. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physio-logic flow. J Exp Med. 1998;188: 1413–9.
   Google Scholar
• Ahn SY, Cho CH, Park KG, Lee RI, Lee S, Park SK, et al. Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-alpha-induced fractalkine expression. Am J Pathol. 2004; 164:1663–72.
   PubMed Web of Science ®Google Scholar
• Imaizumi T, Yoshida H, Satoh K. Regulation of CX3CL1/frac-talkine expression in endothelial cells. J Atheroscler 'Thromb. 2004;11: 15–21.
   Google Scholar
• Bacon PA. Endothelial cell dysfunction in systemic vasculitis: new developments and therapeutic prospects. Curr Opin Rheu-matol. 2005;17:49–55.
   PubMed Web of Science ®Google Scholar
• Kuryliszyn-Moskal A. Cytokines and soluble CD4 and CD8 molecules in rheumatoid arthritis: relationship to systematic vasculitis and microvascular capillaroscopic abnormalities. Clin Rheumatol. 1998;17:489–95.
   PubMed Web of Science ®Google Scholar